H19 and breast cancer: In this study, in silico cross-screening of NGS data for lncRNAs associated with DNA damage response and PARP inhibitor resistance was performed, demonstrating that long noncoding RNA H19 regulates both DDR and sensitivity to PARPis in breast cancer.